BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,288,961 | +128.8% | 13,974 | +24.6% | 0.04% | +104.8% |
| Q3 2023 | $563,418 | -18.2% | 11,219 | +2.9% | 0.02% | -16.0% |
| Q2 2023 | $688,943 | +41.1% | 10,901 | +0.5% | 0.02% | +31.6% |
| Q1 2023 | $488,096 | +149622.7% | 10,849 | +45.7% | 0.02% | +35.7% |
| Q4 2022 | $326 | -99.9% | 7,444 | +0.3% | 0.01% | -36.4% |
| Q3 2022 | $489,000 | +27.0% | 7,420 | -2.6% | 0.02% | +37.5% |
| Q2 2022 | $385,000 | -20.9% | 7,618 | 0.0% | 0.02% | -5.9% |
| Q1 2022 | $487,000 | -40.3% | 7,618 | 0.0% | 0.02% | -37.0% |
| Q4 2021 | $816,000 | +76.2% | 7,618 | +69.2% | 0.03% | +58.8% |
| Q3 2021 | $463,000 | – | 4,503 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 705,159 | $12,728,000 | 12.46% |
| BVF INC/IL | 2,640,251 | $47,657,000 | 11.79% |
| Casdin Capital, LLC | 321,300 | $5,799,000 | 6.66% |
| Opaleye Management Inc. | 220,000 | $3,971,000 | 2.48% |
| PFM Health Sciences, LP | 1,420,511 | $25,640,000 | 0.79% |
| Perceptive Advisors | 404,404 | $7,299,000 | 0.64% |
| Partner Investment Management, L.P. | 18,788 | $339,000 | 0.55% |
| Visium Asset Management, LP | 1,265,025 | $22,834,000 | 0.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 661,717 | $11,944,000 | 0.39% |
| Virtus ETF Advisers LLC | 10,484 | $189,000 | 0.26% |